ALLO
Price
$2.88
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
43 days until earnings call
KRBP
Price
$2.09
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Ad is loading...

ALLO vs KRBP

Header iconALLO vs KRBP Comparison
Open Charts ALLO vs KRBPBanner chart's image
Allogene Therapeutics
Price$2.88
Change-$0.00 (-0.00%)
Volume$2.83M
CapitalizationN/A
Kiromic BioPharma
Price$2.09
Change-$0.00 (-0.00%)
Volume$407
CapitalizationN/A
View a ticker or compare two or three
ALLO vs KRBP Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALLO vs. KRBP commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and KRBP is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (ALLO: $2.88 vs. KRBP: $1.69)
Brand notoriety: ALLO and KRBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 135% vs. KRBP: 84%
Market capitalization -- ALLO: $577.15M vs. KRBP: $2.61M
ALLO [@Biotechnology] is valued at $577.15M. KRBP’s [@Biotechnology] market capitalization is $2.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileKRBP’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • KRBP’s FA Score: 0 green, 5 red.
According to our system of comparison, KRBP is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 6 TA indicator(s) are bullish.

  • ALLO’s TA Score: 6 bullish, 3 bearish.

Price Growth

ALLO (@Biotechnology) experienced а +1.77% price change this week, while KRBP (@Biotechnology) price change was -16.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

ALLO is expected to report earnings on Oct 31, 2024.

KRBP is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLO($577M) has a higher market cap than KRBP($2.61M). KRBP YTD gains are higher at: 94.253 vs. ALLO (-10.280). KRBP has higher annual earnings (EBITDA): -16.53M vs. ALLO (-256.56M). ALLO has more cash in the bank: 445M vs. KRBP (4.05M). KRBP has less debt than ALLO: KRBP (13.4M) vs ALLO (87M). ALLO has higher revenues than KRBP: ALLO (65K) vs KRBP (0).
ALLOKRBPALLO / KRBP
Capitalization577M2.61M22,082%
EBITDA-256.56M-16.53M1,552%
Gain YTD-10.28094.253-11%
P/E RatioN/AN/A-
Revenue65K0-
Total Cash445M4.05M10,993%
Total Debt87M13.4M649%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLO
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BJBIX28.380.07
+0.25%
abrdn Emerging Markets Dividend Class A
DREGX38.03N/A
N/A
Driehaus Emerging Markets Growth Inv
MNMCX15.07N/A
N/A
Manning & Napier Pro-Blend Mod Term L
OIEQX25.67N/A
N/A
JPMorgan Equity Income R4
SGDLX56.37-0.57
-1.00%
Sprott Gold Equity Investor

KRBP and

Correlation & Price change

A.I.dvisor tells us that KRBP and MCRB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KRBP and MCRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRBP
1D Price
Change %
KRBP100%
-6.11%
MCRB - KRBP
27%
Poorly correlated
+7.84%
ENLV - KRBP
25%
Poorly correlated
-1.95%
VKTX - KRBP
25%
Poorly correlated
-6.20%
ALLO - KRBP
24%
Poorly correlated
+4.35%
XRTX - KRBP
24%
Poorly correlated
-5.91%
More